Navigating the Unpredictability of Factor VII Deficiency – EHC
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor VII (FVII) Deficiency
In FVII Deficiency, an extremely rare inherited bleeding disorder, low or missing levels of this protein mean the body struggles to kick-start clot formation, leading to prolonged or unexpected bleeding.
What can this look like?
- Nosebleeds and easy bruising
- Prolonged bleeding after injury or surgery
- Heavy menstrual bleeding
- Bleeding into muscles or joints
- In severe cases, gastrointestinal bleeding or intracranial haemorrhage
One thing to know: symptoms vary widely from person to person, and bleeding severity doesn’t always match Factor VII levels, making this a highly unpredictable condition to live with and diagnose.
Because FVII Deficiency is so rare and so variable, diagnosis is often delayed or missed. Awareness, specialised care, and individualised treatment plans are key to reducing bleeding risk and supporting long-term health.
Want to learn more?
Visit the ERIN Focus Area on the EHC Community website for webinars, podcasts, and publications on extremely rare bleeding disorders.”
Stay updated with Hemostasis Today.
-
Aug 19, 2026, 01:43Elvira Grandone: Cancer and Thrombosis in Women – Where Do We Stand?
-
Aug 19, 2026, 01:37Ifeanyichukwu Ifechidere: Coagulation Knowledge – A Core Skill in Internal Medicine
-
Aug 19, 2026, 01:34Tommy Alfaro Moya: Celebrating a New Chapter Contribution in Clinical Hematology and Hemato-Oncology
-
Aug 19, 2026, 01:29Axay Tomar: Precision Transfusion and Optimizing Blood Component Therapy in Hematology
-
Aug 18, 2026, 19:49Make the Most of Your Summer and Catch Up on Gene Therapy – EAHAD
-
Aug 18, 2026, 19:46Lesley Van Wyk: ANA Testing – From Screening to Interpretation
-
Aug 18, 2026, 19:45Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
-
Aug 18, 2026, 19:42Melanie Jay: What Should Behavioral Support Look Like Alongside Obesity Medications?
-
Aug 18, 2026, 19:40Subodh Verma: Tirzepatide Improves Multiple Cardiovascular Risk Pathways